1. Home
  2. YI vs COCH Comparison

YI vs COCH Comparison

Compare YI & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 111 Inc.

YI

111 Inc.

HOLD

Current Price

$4.13

Market Cap

46.4M

ML Signal

HOLD

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

HOLD

Current Price

$0.75

Market Cap

49.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
YI
COCH
Founded
2010
1995
Country
China
United States
Employees
N/A
47
Industry
Retail-Drug Stores and Proprietary Stores
Blank Checks
Sector
Consumer Staples
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
46.4M
49.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
YI
COCH
Price
$4.13
$0.75
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
34.6K
683.6K
Earning Date
04-09-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.58
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.48
$0.36
52 Week High
$11.17
$1.89

Technical Indicators

Market Signals
Indicator
YI
COCH
Relative Strength Index (RSI) 41.12 63.67
Support Level $3.39 $0.64
Resistance Level $4.88 $0.90
Average True Range (ATR) 0.47 0.07
MACD 0.05 0.02
Stochastic Oscillator 37.50 53.41

Price Performance

Historical Comparison
YI
COCH

About YI 111 Inc.

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Share on Social Networks: